PDS Biotechnology Corp (PDSB)
3.705
+0.10
(+2.63%)
USD |
NASDAQ |
May 02, 16:00
3.705
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Shareholders Equity (Quarterly): 26.13M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.13M |
| September 30, 2023 | 24.48M |
| June 30, 2023 | 32.44M |
| March 31, 2023 | 41.01M |
| December 31, 2022 | 44.00M |
| September 30, 2022 | 47.06M |
| June 30, 2022 | 51.43M |
| March 31, 2022 | 55.87M |
| December 31, 2021 | 63.21M |
| September 30, 2021 | 67.86M |
| June 30, 2021 | 72.99M |
| March 31, 2021 | 24.37M |
| December 31, 2020 | 27.13M |
| September 30, 2020 | 31.02M |
| June 30, 2020 | 17.01M |
| March 31, 2020 | 19.89M |
| December 31, 2019 | 11.70M |
| September 30, 2019 | 15.58M |
| Date | Value |
|---|---|
| June 30, 2019 | 20.61M |
| March 31, 2019 | 24.45M |
| December 31, 2018 | 29.84M |
| September 30, 2018 | 30.98M |
| June 30, 2018 | 33.34M |
| March 31, 2018 | 44.28M |
| December 31, 2017 | 62.37M |
| September 30, 2017 | 74.65M |
| June 30, 2017 | 84.27M |
| March 31, 2017 | 78.65M |
| December 31, 2016 | 89.28M |
| September 30, 2016 | 97.51M |
| June 30, 2016 | 106.76M |
| March 31, 2016 | 114.72M |
| December 31, 2015 | 122.48M |
| September 30, 2015 | -50.64M |
| June 30, 2015 | 52.14M |
| December 31, 2014 | -27.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.70M
Minimum
Dec 2019
72.99M
Maximum
Jun 2021
36.52M
Average
31.02M
Median
Sep 2020
Shareholders Equity (Quarterly) Benchmarks
| Syros Pharmaceuticals Inc | 16.66M |
| PAVmed Inc | -53.83M |
| Altimmune Inc | 194.10M |
| Regeneron Pharmaceuticals Inc | 25.97B |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.39M |
| Total Liabilities (Quarterly) | 33.26M |